Revisiting the TCA cycle: signaling to tumor formation
- PMID: 21764377
- PMCID: PMC3205302
- DOI: 10.1016/j.molmed.2011.06.001
Revisiting the TCA cycle: signaling to tumor formation
Abstract
A role for mitochondria in tumor formation is suggested by mutations in enzymes of the TCA cycle: isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH) and fumarate hydratase (FH). Although they are all components of the TCA cycle, the resulting clinical presentations do not overlap. Activation of the hypoxia pathway can explain SDH phenotypes, but recent data suggest that FH and IDH mutations lead to tumor formation by repressing cellular differentiation. In this review, we discuss recent findings in the context of both mitochondrial and cytoplasmic components of the TCA cycle, and we propose that extrametabolic roles of TCA cycle metabolites result in reduced cellular differentiation. Furthermore, activation of the pseudohypoxia pathway likely promotes the growth of these neoplasias into tumors.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
References
-
- Scheffler IE. Mitochondria. 2nd ed John Wiley & Sons, Inc.; Hoboken, New Jersey , U.S.A.: 2008.
-
- Ishikawa K, Hayashi J. A novel function of mtDNA: its involvement in metastasis. Ann N Y Acad Sci. 2010;1201:40–3. - PubMed
-
- Baysal BE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
